New Chemical May Halt HIV Infection
...e strains of the HIV virus. The chemical was developed by the scientists at Brigham Young University, Utah, and is licensed to a company called ceragenix Pharmaceuticals. Brigham Young University and Vanderbilt have jointly filed a patent on the compounds. The research is still at its early stages, and ...Ceragenix Announces Ceragenins Virtually Prevent Catheter Biofilm Formation in 21 Day Study
... DENVER--(BUSINESS WIRE)--Mar 12, 2007 - ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP), a biopharmaceu...is the inventor of the Ceragenin technology, which ceragenix has exclusively licensed from Brigham Young Univer... Account # 286 Conference ID #: 232309 About ceragenix ...Ceragenix Announces New Publication of Scientific Research on Ceragenin Technology
... DENVER--(BUSINESS WIRE)--Apr 23, 2007 - ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP), a biopharmaceu... promising in vitro data." Steven Porter, CEO of ceragenix stated: "The publication of peer-reviewed research...work that is now being conducted in vivo." About ceragenix ...Ceragenix Announces Results from Phase IV Study of EpiCeram Meet All Primary and Secondary Endpoints
... DENVER--(BUSINESS WIRE)--Apr 24, 2007 - ceragenix Pharmaceuticals Inc. (OTCBB:CGXP) today announced ...d a black box safety warning from the FDA. About ceragenix ceragenix Pharmaceuticals, Inc. is a biopharmaceutical compa...Ceragenix Compound Shows Promise for Treating Lethal Cystic Fibrosis Infections
... DENVER--(BUSINESS WIRE)--Jul 2, 2007 - ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP), a biopharmaceu...fections," said Steven Porter, Chairman and CEO of ceragenix Pharmaceuticals. "Our goal is to find a partner to... advance development of this application." About ceragenix ...